NCT06466278View on ClinicalTrials.gov

IcoSApent ethyL to Slow Down Aortic VAlve Stenosis proGrEssion

PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

July 1, 2026

Study Completion Date

December 1, 2026

Conditions

Aortic Valve Stenosis

Interventions

DRUG

Icosapent ethyl

2dd2

DRUG

Placebo

2dd2

Trial Locations (1)

1105AZ

Academic Medical Center, Amsterdam

All Listed Sponsors

lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER